









Markets
/
Stocks
/
nasdaq-mbx
/

MBX Biosciences Inc

MBX

30.900USD

-1.210-3.77%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

1.38BMarket Cap

LossP/E TTM



MBX Biosciences Inc

30.900

-1.210-3.77%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of MBX Biosciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-46.86%-21.54M

-31.38%-17.43M

-111.75%-22.68M

-43.88%-16.04M

-89.80%-14.66M

-79.79%-13.27M

-87.07%-10.71M

---11.15M

---7.73M

---7.38M

---5.72M

Net income from continuing operations

-19.16%-21.62M

-22.41%-19.41M

-93.56%-23.88M

-76.25%-15.59M

-78.51%-18.14M

-108.43%-15.86M

-107.38%-12.34M

---8.84M

---10.16M

---7.61M

---5.95M

Operating gains losses

-33.33%50.00K

-3.17%61.00K

60.42%77.00K

41.46%58.00K

87.50%75.00K

61.54%63.00K

29.73%48.00K

--41.00K

--40.00K

--39.00K

--37.00K

Other non-cash items

-25.36%-702.00K

-126.81%-939.00K

-174.90%-1.31M

-138.26%-1.37M

-6322.22%-560.00K

-197.84%-414.00K

-95.90%-478.00K

---575.00K

--9.00K

---139.00K

---244.00K

Change in working capital

-154.53%-1.51M

-54.53%918.00K

38.25%600.00K

78.05%-627.00K

54.63%2.77M

1879.41%2.02M

91.19%434.00K

---2.86M

--1.79M

--102.00K

--227.00K

-Change in prepaid expenses

-171.53%-1.54M

31.35%-795.00K

303.92%1.65M

22.16%-1.03M

-562.60%-569.00K

-687.76%-1.16M

36.45%408.00K

---1.32M

--123.00K

---147.00K

--299.00K

-Change in other current assets

--65.00K

---566.00K

----

--0.00

---8.00K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-46.86%-21.54M

-31.38%-17.43M

-111.75%-22.68M

-43.88%-16.04M

-89.80%-14.66M

-79.79%-13.27M

-87.07%-10.71M

---11.15M

---7.73M

---7.38M

---5.72M

Investing cash flow

Net cash from continuing investing activities

600.00%399.00K

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Capital expenditures

600.00%399.00K

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Net cash flow from disposal of fixed assets

600.00%399.00K

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Net cash flow from investment products

117.33%17.45M

458.83%26.69M

-79.26%3.26M

-132.71%-67.25M

-442.06%-100.73M

-137.19%-7.44M

573.67%15.70M

---28.90M

---18.58M

--20.00M

---3.31M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

116.92%17.06M

429.31%25.99M

-79.09%3.23M

-132.59%-67.34M

-441.73%-100.79M

-139.52%-7.89M

562.50%15.43M

---28.95M

---18.61M

--19.97M

---3.34M

Financing cash flow

Cash flow from continuous financing activities

-20.35%187.82M

175.30%1.33M

-97.81%4.00K

-794.74%-132.00K

244.27%235.81M

-377.76%-1.76M

165.22%183.00K

--19.00K

--68.50M

--634.00K

--69.00K

Net cash flow from debt Issuance/repayment

----

--0.00

----

Net cash flow from common stock issuance/repurchase

7.68%187.95M

----

--0.00

--174.54M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-7.31%63.50M

----

--0.00

--68.51M

----

Proceeds from stock option exercised by employees

519.35%130.00K

2552.00%1.33M

-97.88%4.00K

926.32%195.00K

-282.35%-31.00K

-92.11%50.00K

173.91%189.00K

--19.00K

--17.00K

--634.00K

--69.00K

Net cash flow from other financing activities

88.44%-254.00K

100.00%0.00

---327.00K

-7223.33%-2.20M

---1.81M

---6.00K

--0.00

---30.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-20.35%187.82M

175.30%1.33M

-97.81%4.00K

-794.74%-132.00K

244.27%235.81M

-377.76%-1.76M

165.22%183.00K

--19.00K

--68.50M

--634.00K

--69.00K

Net cash flow

Beginning cash balance

218.17%39.78M

-15.59%29.90M

61.68%49.35M

88.18%132.87M

-56.04%12.50M

132.78%35.42M

26.08%30.52M

--70.61M

--28.44M

--15.22M

--24.21M

Current period cash flow changes

52.33%183.34M

143.09%9.88M

-496.74%-19.45M

-108.36%-83.51M

185.45%120.36M

-273.36%-22.92M

154.52%4.90M

---40.08M

--42.16M

--13.22M

---8.99M

Ending cash balance

67.93%223.13M

218.17%39.78M

-15.59%29.90M

61.68%49.35M

88.18%132.87M

-56.04%12.50M

132.78%35.42M

--30.52M

--70.61M

--28.44M

--15.22M

Free cash flow

-49.00%-21.93M

-32.20%-18.14M

-106.76%-22.71M

-44.00%-16.13M

-90.00%-14.72M

-85.13%-13.72M

-91.14%-10.98M

---11.20M

---7.75M

---7.41M

---5.75M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

